Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 153.00M | £ 166.00M | £ 166.50M | £ 101.40M | £ 115.10M |
Total Assets | £ 1.83B | £ 1.77B | £ 1.78B | £ 1.72B | £ 1.82B |
Total Debt | £ 520.20M | £ 479.90M | £ 497.10M | £ 508.40M | £ 620.10M |
Net Debt | £ 367.20M | £ 313.90M | £ 330.60M | £ 407.00M | £ 505.00M |
Total Liabilities | £ 808.50M | £ 717.90M | £ 768.10M | £ 730.30M | £ 878.00M |
Stockholders Equity | £ 1.02B | £ 1.05B | £ 1.01B | £ 993.70M | £ 940.30M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |